2023
DOI: 10.36346/sarjm.2023.v04i05.001
|View full text |Cite
|
Sign up to set email alerts
|

Hydroxychloroquine as ‘Potential Treatment Option’ for Persistent Immune Dysregulation in Long COVID: Revisiting Its New Use as a ‘Versatile’ Molecule!

Shital Patil,
Swati Patil,
Gajanan Gondhali

Abstract: COVID-19 pandemic is over now and we are in great peace of relief after three years of first case reported in China. This pandemic has observed a significant impact on quality of life globally and this puts unforgettable imprints on the history of mankind. Reason for more havoc in this pandemic was less studied virus before this ‘unpredicted or surprise pandemic’ by medical scientists regarding its pathophysiology, available treatment options and lack of effective vaccine to tackle this dragon. Rationale would… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 39 publications
(51 reference statements)
0
3
0
Order By: Relevance
“…Immune dysregulation has documented during course of active viremia, during recovery of viral illness and after post viral phase. Immune dysregulation occurs in 'selected group' of cases irrespective of disease severity and vaccination status and observed in cases with negligible illness to advanced one mandates further research [27,28]. HCQ was tried initially for prophylaxis treatment of COVID-19 due to its anti-inflammatory properties but has not shown any dramatic results.…”
Section: Discussionmentioning
confidence: 99%
“…Immune dysregulation has documented during course of active viremia, during recovery of viral illness and after post viral phase. Immune dysregulation occurs in 'selected group' of cases irrespective of disease severity and vaccination status and observed in cases with negligible illness to advanced one mandates further research [27,28]. HCQ was tried initially for prophylaxis treatment of COVID-19 due to its anti-inflammatory properties but has not shown any dramatic results.…”
Section: Discussionmentioning
confidence: 99%
“…Immune dysregulation has documented during course of active viremia, during recovery of viral illness and after post viral phase. Immune dysregulation occurs in 'selected group' of cases irrespective of disease severity and vaccination status and observed in cases with negligible illness to advanced one mandates further research [27][28]. HCQ was tried initially for prophylaxis treatment of COVID-19 due to its anti-inflammatory properties but has not shown any dramatic results.…”
Section: Discussionmentioning
confidence: 99%
“…HCQ is a drug with multiple beneficial pleiotropic effects such as immunomodulatory effects which regulates immunological responses that inhibit dysregulated immune system. Revisiting this old drug with 'versatile effects' can be used as treatment option for short time as frontline molecule for Long covid when no definitive options are available after consideration of risk benefit ratio which is a costeffective treatment option [27]. L-Arginine is amino acid with multiple beneficial effects such as immunomodulatory effects which will regulates immunological response in inhibit dysregulated immune system additional to its universally known antioxidant, vasodilatory and regenerative and cellular proliferation effects on immune cells.…”
Section: Discussionmentioning
confidence: 99%